Purification and properties of heparin-releasable lipoprotein- associated coagulation inhibitor

WF Novotny(Jewish Hospital), JP Miletich(Washington University in St. Louis), GJ Jr Broze(Jewish Hospital), TC Wun(Jewish Hospital), Mark O. Palmier(Jewish Hospital)
Blood
July 15, 1991
10.1182/blood.v78.2.394.bloodjournal782394
Cited by 16

Related Papers

The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action
|Blood|1988|480
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples
|Blood|1991|240
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor
|Blood|1988|221
Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples
|Blood|1991|212
Platelets secrete a coagulation inhibitor functionally and antigenically similar to the lipoprotein associated coagulation inhibitor
|Blood|1988|211